Blood Cancer United
Overview
Blood Cancer United is a non-profit health organization and venture philanthropy investor dedicated to curing blood cancer and improving the quality of life for patients and their families by funding research and making strategic equity investments to accelerate new therapies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Crossbow Therapeutics | Mar 2026 | Series B | Co-investor |
| BioTheryX | Nov 2010 | Series A | Lead |
| Dimericon Therapeutics | May 2023 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Blood Cancer United based?
Blood Cancer United is headquartered in Washington D.C., United States.
When was Blood Cancer United founded?
Blood Cancer United was founded in 1949.
How many portfolio companies does Blood Cancer United have?
Blood Cancer United has 3 portfolio companies in Caplight's dataset.
What are some companies in Blood Cancer United's portfolio?
Portfolio companies visible on Caplight include Crossbow Therapeutics, BioTheryX, Dimericon Therapeutics.
What was Blood Cancer United's most recent investment shown here?
Blood Cancer United's most recent investment in this portfolio sample was in Crossbow Therapeutics in 2026.
What sectors does Blood Cancer United focus on?
Blood Cancer United focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Blood Cancer United focus on?
Blood Cancer United typically invests at the Mid stage.